To view this email as a web page, go here.

Message below is a paid advertisement. Content is provided by the sponsor.

Earn up to
1.5 AMA PRA Category 1 Credits™
1.5 contact hours (0.15 CEUs)
1.5 ACHE Qualified Education Hours
 

W. Lloyd Clark, MD (Co-Chair)
Assistant Clinical Professor of Ophthalmology
University of South Carolina School of Medicine
Retina Specialist, Palmetto Retina Center
Columbia, South Carolina

Winston Wong, PharmD (Co-Chair)
President
W-Squared Group
Longboat Key, Florida

Jeffrey S. Heier, MD
Co-President and Medical Director
Ophthalmic Consultants of Boston
Boston, Massachusetts

Gary Owens, MD
President
Gary Owens Associates
Ocean View, Delaware
 
Target Audience

This activity is intended for managed care clinical and nonclinical executives engaged in the care of patients with neovascular age-related macular degeneration (nAMD).


Educational Objectives

After completing this activity, the participant should be better able to:

• Explain current practice patterns for the treatment of patients with nAMD
• Outline the benefits of collaboration between payers and providers

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and i mplemented by the Postgraduate Institute for Medicine and MedEdicus LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


   Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s)
(0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008162-9999-18-408-H01-P)

Type of Activity: Knowledge


ACHE Qualified Education 

By attending the Understanding the Treatment Paradigm for Age-Related Macular Degeneration offered by Postgraduate Institute for Medicine, participants may earn up to 1.5 ACHE Qualified Education Hours toward initial certification or recertification of the Fellow of the American College of Healthcare Executives (FACHE) designation.


 

Jointly provided by Postgraduate Institute for Medicine and MedEdicus LLC

This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

Distributed with Managed Healthcare Executive

©2018 MedEdicus LLC.
MedEdicus LLC, 73 Redding Road, PO Box 839, Georgetown CT 06829
If you do not wish to receive email from MedEdicus in the future, please click here.

 


You received this e-mail because you are a customer of Managed Healthcare Executive, a UBM publication. You are on the mailing list as ksponza@mededicus.com

To ensure delivery to your Inbox, please add us to your address book.

From time to time, we will inform customers of latest offers and new products from relevant business partners. If you do not wish to receive this type of information, click here.

If you would like to contact us by phone, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-7223. Outside the U.S., please phone 1-218-740-6895.

Managed Healthcare Executive, a UBM publication
325 W 1st St Ste 300,
Duluth, MN 55802-2065 USA.
Privacy Policy